J AM ACAD DERMATOL - Journal of the American Academy of Dermatology

Publications

  1. 2022
  2. Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial

    Blauvelt, A., Langley, R. G., Lacour, J-P., Toth, D., Laquer, V., Beissert, S., Wollenberg, A., Herranz, P., Pink, A. E., Peris, K., Fangel, S., Gjerum, L., Corriveau, J., Saeki, H., Warren, R. B., Simpson, E. & Reich, K., 10.2022, In: J AM ACAD DERMATOL. 87, 4, p. 815-824 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2021
  4. Immunoglobulin M pemphigoid

    Boch, K., Hammers, C. M., Goletz, S., Kamaguchi, M., Ludwig, R. J., Schneider, S. W., Zillikens, D., Hadaschik, E. & Schmidt, E., 12.2021, In: J AM ACAD DERMATOL. 85, 6, p. 1486-1492 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis

    Langley, R. G., Poulin, Y., Srivastava, B., Lafferty, K. P., Fakharzadeh, S., Langholff, W. & Augustin, M., 01.2021, In: J AM ACAD DERMATOL. 84, 1, p. 60-69 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2020
  7. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

    Simpson, E., Bissonnette, R., Eichenfield, L. F., Guttman-Yassky, E., King, B., Silverberg, J. I., Beck, L. A., Bieber, T., Reich, K., Kabashima, K., Seyger, M., Siegfried, E., Stingl, G., Feldman, S. R., Menter, A., van de Kerkhof, P., Yosipovitch, G., Paul, C., Martel, P., Dubost-Brama, A., Armstrong, J., Chavda, R., Frey, S., Joubert, Y., Milutinovic, M., Parneix, A., Teixeira, H. D., Lin, C-Y., Sun, L., Klekotka, P., Nickoloff, B., Dutronc, Y., Mallbris, L., Janes, J. M., DeLozier, A. M., Nunes, F. P. & Paller, A. S., 09.2020, In: J AM ACAD DERMATOL. 83, 3, p. 839-846 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab

    Smith, S. D., Conrad, C., Ramharter, M., Gottlieb, A. B., Patel, H., Xu, W., Riedl, E. & Schuster, C., 07.2020, In: J AM ACAD DERMATOL. 83, 1, p. 261-263 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  9. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials

    Reich, K., Griffiths, C. E. M., Gordon, K. B., Papp, K. A., Song, M., Randazzo, B., Li, S., Shen, Y-K., Han, C., Kimball, A. B., Armstrong, A. W., Foley, P. & Blauvelt, A., 04.2020, In: J AM ACAD DERMATOL. 82, 4, p. 936-945 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

    Deleuran, M., Thaçi, D., Beck, L. A., de Bruin-Weller, M., Blauvelt, A., Forman, S., Bissonnette, R., Reich, K., Soong, W., Hussain, I., Foley, P., Hide, M., Bouaziz, J-D., Gelfand, J. M., Sher, L., Schuttelaar, M. L. A., Wang, C., Chen, Z., Akinlade, B., Gadkari, A., Eckert, L., Davis, J. D., Rajadhyaksha, M., Staudinger, H., Graham, N. M. H., Pirozzi, G. & Ardeleanu, M., 02.2020, In: J AM ACAD DERMATOL. 82, 2, p. 377-388 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. 2018
  12. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial

    Steinke, S., Zeidler, C., Riepe, C., Bruland, P., Soto-Rey, I., Storck, M., Augustin, M., Bobko, S., Garcovich, S., Legat, F. J., Lvov, A., Misery, L., Osada, N., Reich, A., Şavk, E., Serra-Baldrich, E., Streit, M., Szepietowski, J. C., Weger, W., Dugas, M. & Ständer, S., 09.2018, In: J AM ACAD DERMATOL. 79, 3, p. 457-463.e5

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: Results Through 48 Weeks of a Phase 3, Multicenter, Randomized, Double-Blinded, Etanercept- and Placebo-Controlled Study (CIMPACT)

    Lebwohl, M., Blauvelt, A., Paul, C., Sofen, H., Węgłowska, J., Piguet, V., Burge, D., Rolleri, R., Drew, J., Peterson, L. & Augustin, M., 08.2018, In: J AM ACAD DERMATOL. 79, 2, p. 266-276.e5

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study

    Puig, L., Augustin, M., Blauvelt, A., Gottlieb, A. B., Vender, R., Korman, N. J., Thaçi, D., Zhao, Y., Gilloteau, I., Sherif, B., Williams, N., Guana, A. & Lebwohl, M. G., 04.2018, In: J AM ACAD DERMATOL. 78, 4, p. 741-748 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. 2016
  16. Tofacitinib Improves Pruritus and Health-Related Quality of Life up to 52 weeks: Results from 2 Randomized Phase III Trials in Patients With Moderate to Severe Plaque Psoriasis

    Feldman, S. R., Thaçi, D., Gooderham, M., Augustin, M., de la Cruz, C., Mallbris, L., Buonanno, M., Tatulych, S., Kaur, M., Lan, S., Valdez, H. & Mamolo, C., 12.2016, In: J AM ACAD DERMATOL. 75, 6, p. 1162-1170

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2015
  18. Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes

    Augustin, M., Tu, J. H., Knudsen, K. M., Erntoft, S., Larsson, T. & Hanke, C. W., 05.2015, In: J AM ACAD DERMATOL. 72, 5, p. 816-821 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. 2011
  20. Ovicidal efficacy of high concentration dimeticone: a new era of head lice treatment

    Heukelbach, J., Sonnberg, S., Becher, H., Melo, I., Speare, R. & Oliveira, F. A., 01.04.2011, In: J AM ACAD DERMATOL. 64, 4, p. e61-2

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. 2010
  22. The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial.

    Menter, A., Augustin, M., Signorovitch, J., Yu, A. P., Wu, E. Q., Gupta, S. R., Bao, Y. & Mulani, P., 2010, In: J AM ACAD DERMATOL. 62, 5, p. 812-818 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. 2004
  24. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma.

    Coors, E. & von den Driesch, P., 2004, In: J AM ACAD DERMATOL. 50, 3, p. 363-367 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. 2002
  26. Bilateral temporal arteritis.

    Coors, E. & Simon, M., 2002, In: J AM ACAD DERMATOL. 46, 2, p. 14-15 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Localized cutaneous small to medium-sized pleomorphic T-cell lymphoma: a report of 3 cases stable for years.

    von den Driesch, P. & Coors, E., 2002, In: J AM ACAD DERMATOL. 46, 4, p. 531-535 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review